University Hospital Erlangen at ESGCT 2026

Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website

University Hospital Erlangen brings 2 presentations to ESGCT 2026 in Hamburg. Its work centres on cell therapy for autoimmune disease. Topics include whether CAR T cells can cure autoimmune conditions and expanded regulatory T cells given back to patients with ulcerative colitis.

OrganizationESGCT 2026 Attendance
uk-erlangen.de
Hospitals & clinical centres
German university hospital that has treated autoimmune diseases such as lupus with CD19 CAR-T cells.
Talk
Wed Oct 28
11:30am–12:30pm
Can CAR-T cells cure autoimmune disease?
SESSION 4c: Immunotherapy and CAR T cells II
Cell therapies and CAR-TClinical trials and translation
Poster
Wed Oct 28
1:30pm–3:30pm
Engineered ex vivo expanded regulatory T cells for autologous adoptive transfer therapy of ulcerative colitis
Other
Cell therapies and CAR-T

Explore the full ESGCT 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Hamburg. Leave your work email and we’ll be in touch.

Privacy

Download the full ESGCT 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University Hospital Erlangen

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction